Get the Stockscreener App
6.63
5.07%
0.32
After Hours:
6.63
Lifeward Ltd stock is traded at $6.63, with a volume of 5,026.
It is up +5.07% in the last 24 hours and down -10.41% over the past month.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
See More
Previous Close:
$6.31
Open:
$6.4
24h Volume:
5,026
Relative Volume:
0.20
Market Cap:
$10.13M
Revenue:
$22.03M
Net Income/Loss:
$-19.91M
P/E Ratio:
-0.3581
EPS:
-18.5136
Net Cash Flow:
$-16.84M
1W Performance:
+3.76%
1M Performance:
-10.41%
6M Performance:
-22.36%
1Y Performance:
-67.50%
1-Day Range:
$6.30
$6.63
1-Week Range:
$6.08
$6.645
52-Week Range:
$4.14
$21.78
Lifeward Ltd Stock (LFWD) Company Profile
Name
Lifeward Ltd
Sector
Industry
Phone
15082511154
Address
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.63 | 9.64M | 22.03M | -19.91M | -16.84M | -18.51 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Initiated | Laidlaw | Buy |
| Apr-03-17 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-16-16 | Initiated | Oppenheimer | Outperform |
| Jul-15-16 | Initiated | Piper Jaffray | Overweight |
| May-22-15 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-08-15 | Reiterated | Barclays | Equal Weight |
| Oct-07-14 | Initiated | Barclays | Equal Weight |
View All
Lifeward Ltd Stock (LFWD) Latest News
Lifeward Ltd. 8-K SEC Filing March 2026: Company Information, NASDAQ Listing, and Entity Details - Minichart
Lifeward Restores Nasdaq Compliance With Audit Committee Changes - TipRanks
Lifeward regains Nasdaq compliance after audit committee appointments By Investing.com - in.investing.com
Lifeward regains Nasdaq compliance after audit committee appointments - Investing.com
Lifeward regains Nasdaq audit committee compliance after new appointments - TradingView
Lifeward (NASDAQ: LFWD) regains Nasdaq audit committee compliance after board change - stocktitan.net
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - stocktitan.net
Dow Update: Will Lifeward Ltd outperform small cap indexesMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward (LFWD) price target increased by 344.44% to 20.40 - MSN
Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares - stocktitan.net
Lifeward (LFWD) CEO awarded 172,698 options at $6.53 strike - stocktitan.net
Director at Lifeward (LFWD) granted 7,657 RSUs vesting quarterly - stocktitan.net
Lifeward (LFWD) director receives 7,657 RSU grant under 2025 plan - stocktitan.net
Director Miriam Kidron receives 7,657-share RSU grant at Lifeward (NASDAQ: LFWD) - stocktitan.net
Lifeward (LFWD) director Reznick Yehuda files initial insider Form 3 - stocktitan.net
Lifeward (LFWD) director Nadav Kidron submits initial Form 3 ownership - stocktitan.net
Lifeward (LFWD) director Miriam Kidron submits initial Form 3 insider report - stocktitan.net
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - stocktitan.net
Lifeward Completes Oratech Acquisition and Secures Private Financing - The Globe and Mail
Aug Spikes: Is Lifeward Ltd in a long term uptrend2026 Levels & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia
Lifeward Ltd. 8-K Filing: Share Purchase Agreement Assignment to Oratech Ltd. and Entity Information (March 2026) - Minichart
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward (NASDAQ: LFWD) closes Oratech buy with new shares and $10M notes - stocktitan.net
Lifeward adds biotech drug-delivery tech and taps up to $47M - stocktitan.net
Insider Sell: Is Lifeward Ltd affected by consumer sentiment2026 Decliners & Target Return Focused Stock Picks - baoquankhu1.vn
Lifeward Successfully Closes on Strategic Partnership with Oramed - Bitget
Lifeward Ltd. completed the acquisition of Oratech Pharma, Inc. from Oramed Pharmaceuticals Inc.. - marketscreener.com
If You Invested $1,000 in Lifeward Ltd (LFWD) - stocktitan.net
Lifeward Faces Nasdaq Audit Committee Compliance Challenge - The Globe and Mail
Aug Levels: Is Lifeward Ltd a speculative investmentQuarterly Market Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Lifeward Ltd. Files Form 8-K with SEC – Key Company Information and Filing Details for March 2026 - Minichart
Lifeward Shares Rise 5.1% on Expanded Distribution Deal in UAE and GCC - MSN
Lifeward Received Notice of Noncompliance - TradingView
Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice - Stock Titan
LFWD Stock: HC Wainwright & Co. Raises Price Target to $10.00 | - gurufocus.com
Lifeward stock price target raised to $10 on partnership strength By Investing.com - Investing.com Canada
Risk Report: Will Lifeward Ltd stock hit new highs in YEARPortfolio Update Summary & High Return Trade Guides - baoquankhu1.vn
Lifeward stock price target raised to $10 on partnership strength - Investing.com UK
Lifeward reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
Lifeward Q4 2025 Earnings Call Transcript - MarketBeat
Lifeward Ltd (LFWD) Q4 2025 Earnings Call Highlights: Strategic Moves and Market Challenges - GuruFocus
Lifeward Ltd. Announces Strategic Expansion, Acquisition of Exoskeleton Technology, and Improved 2025 Financial Results - Minichart
Lifeward Ltd’s 2025 Earnings Call: Revenue Miss, Medicare Pipeline Discrepancies, and Timelines Clash - Bitget
Lifeward 2025 10-K: Revenue $22.0M, Gross Profit $8.4M - TradingView
Lifeward (LFWD) expands neurorehab platform with Oramed deal and Medicare gains - Stock Titan
Lifeward (LFWD) Pursues Growth with New Strategic Partnership - GuruFocus
Lifeward (LFWD) 2025 Financials: Q4 Revenue $5.1M, Annual Loss $19.9MNews and Statistics - IndexBox
Lifeward: Overview of Fourth Quarter Financial Results - Bitget
Lifeward Ltd Stock (LFWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifeward Ltd Stock (LFWD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jasinski Lawrence J | Chief Executive Officer |
May 21 '25 |
Sale |
1.26 |
1,909 |
2,405 |
98,728 |
2.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):